发明名称 |
Method of using estrogen-related receptor gamma (ERRgamma) status to determine prognosis and treatment strategy for breast cancer, method of using ERRgamma as a therapeutic target for treating breast cancer, method of using ERRgamma to diagnose breast cancer, and method of using ERRgamma to identify individuals predisposed to breast cancer |
摘要 |
The present invention provides that ERRgamma is both a breast cancer biomarker and a breast cancer treatment target. A high ERRgamma level in breast cancer cells indicates good prognosis. A high level of ERRgamma in breast tissue suspected of being cancerous is indicative of breast cancer. Analyzing ERRgamma status and optionally along with the status of ERalpha can help breast cancer patients make treatment choices. Furthermore, breast cancer can be treated by decreasing ERRgamma activity in breast cancer cells.
|
申请公布号 |
US2004142490(A1) |
申请公布日期 |
2004.07.22 |
申请号 |
US20030654253 |
申请日期 |
2003.09.03 |
申请人 |
MERTZ JANET E.;ARIAZI ERIC ANTHONY |
发明人 |
MERTZ JANET E.;ARIAZI ERIC ANTHONY |
分类号 |
G01N33/564;G01N33/574;(IPC1-7):G01N33/564 |
主分类号 |
G01N33/564 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|